Photopheresis in cutaneous T-cell lymphoma: Five-year experience

International Journal of Artificial Organs

Volumn 23, Issue 1, 2000, Pages 55-62

  Crovetti, Giovanni ^a,b   Carabelli, A ^a   Berti, E ^c   Guizzardi, M ^c   Fossati, S ^c   De Filippo, C ^a   Bertani, E ^a  

^a Photopheresis Department   (Italy)

^b Serv Trasfusionale Osp Sant'A   (Italy)

^c NONE

Author keywords

CD95 (Apo I Fas); Cutaneous T cell lymphoma; IFN ; Photopheresis

Indexed keywords

BLOOD; CELL PROLIFERATION; ONCOLOGY; T-CELLS;

CD95 (APO I/FAS); CLINICAL RESPONSE; COMPLETE RESPONSE; CUTANEOUS T-CELL LYMPHOMA; IFN-Α; PARTIAL RESPONSE; PHOTOCHEMOTHERAPY; PHOTOPHERESIS; SIDE EFFECT; T LYMPHOCYTES;

CHEMOTHERAPY;

ALPHA INTERFERON; ANTIGEN; FAS ANTIGEN; LACTATE DEHYDROGENASE; METHOXSALEN; RETINOID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; MYCOSIS FUNGOIDES; PUVA; T CELL LYMPHOMA; TREATMENT OUTCOME;

EID: 0033993654     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880002300109     Document Type: Article

References (31)

1. Edelson RL, Berger CL, Raafat J, et al. Karyotype studies of cutaneous T cell lymphoma: evidence for clonal origin. J Invest Dermatol 1979; 73: 548-50.
2. Murphy GF. Cutaneous T cell lymphoma. Adv Pathol 1988; 1: 131-56.
3. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European organization for research and treatment of cancer. Blood 1997; 90: 354-71.
4. Springer ES, Kuzel TM, Rosen ST. International symposium on cutaneous T cell Lymphoma. J Am Acad Dermatol 1991; 24: 136-8.
5. Sézary A, Bouvrain Y. Erythroderma avec presence de cellules monstrueses dans le derme el le sang circulant. Bull Soc Fr Dermatol Syphil 1938; 45: 357-68
6. Willemze R, van Vloten WA, Hermans J et al. Diagnostic criteria in Sézary's syndrome. A multiparameter study of peripheral blood lymphocytes in 32 patients with erythroderma. J Invest Dermatol 1983; 81: 392-7
7. Gilchrest BA, Parrish JA, Tanenbaum L, et al. Oral methoxoralen photochemotherapy of mycosis fungoides. Cancer 1976; 38: 683-9.
8. Vonderheid EC, Tan ET, Kantor AF, et al. Long term efficacy, curative potential and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma. J Am Acad Dermatol 1989; 20: 416-28.
9. Zackheim HS, Epstein EH, Crain WR. Topical carmustine (BCNU) for cutaneous T cell lymphoma: a 15 years experience in 143 patiens. J Am Acad Dermatol 1990; 22: 802-10.
10. Bunn PA, Foon KA, Ihde DC, et al. Recombinant leukocyte α-interferon: an active agent in advanced cutaneous T-cell lymphomas. Ann Intern Med 1984; 101: 484-7.
11. Thomsen K, Hammar H, Molin L, et al. Retinoids plus PUVA (RePUVA) in mycosis fungoides plaque stage, Acta Derm Venerol (Stock) 1989; 69: 536-8.
12. Hoppe R. The management of mycosis fungoides at Stanford University - standard and innovative treatment programs. Leukemia 1991; 5(s): 46-8.
13. Mc Donald C, Bertino J. Treatment of mycosis fungoides lymphoma: effectiveness of infusions of methotrexate followed by oral citrovorum factor. Cancer Treat Rep 1978; 62: 1009-14.
14. Bierman PJ, Vose JM, Armitage JO. Clinical manifestation and staging of and therapy for non Hodgkin's lymphomas. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen Hj, Silberstein LE eds. Hematology. Basic principles and practice. Churchill-Livingstone II ed, 1995: 1278-98.
15. Edelson R, Berger C, Gasparro F, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med 1987; 316: 297-303.
16. Lim HW, Edelson R. Photopheresis for the treatment of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995; 9: 1117-26.
17. Heald P, Rook A, Perez M, et al. Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol 1992; 27: 427-33.
18. Perez M, Edelson R, LaRoche L, et al. Inhibition of antiskin allograft immunity by infusions with syngenic photoinactivated effector lymphocytes. J Invest Dermatol 1989; 92: 669-76.
19. Song PS, Tapley KJ. Photochemistry and photobiology of psoralens. Photochem Photobiol 1979; 29: 1177-97.
20. Edelson R, Heald P, Perez M, Berger C. Extracorporeal Photochemotherapy. Biologic Therapy of Cancer 1994; 4: 1-12.
21. Heald PW, Kim HY, Perez M, et al. T-cell responses in photoimmune therapy. J Clin Apheresis 1995; 10: 144-9.
22. Vowels B, Cassin M, Boufal M, et al. Extracorporeal photochemotherapy induces the production of tumor necrosis factor-α by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol 1992; 98: 686-92.
23. Yoo EK, Rook AH, Elenitsas R, et al. Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 1996; 107: 235-42.
24. Bunn PA, Lamberg SI. Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 1979; 63: 725-8.
25. Bogen SA, Pelley D, Charif M, et al. Immunophenotypic identification of Sézary cells in peripheral blood. Am J Clin Pathol 1996; 106: 739-48.
26. Bernengo MG, Quaglino P, Novelli P, et al. Prognostic factors in Sézary syndrome: a multivariate analysis of clinical hematological and immunological features. Ann Oncol 1998; 9: 857-63.
27. Knobler RM, Trautinger F, Graninger W, et al. Parenteral administration of 8-methoxypsoralen in photopheresis. J Am Acad Dermatol 1993; 25: 580.
28. Rook AH, Gottlieb SL, Wolfe JT, et al. Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis. Clin Exp Immunol 1997; 107(suppl): S16-20.
29. Gottlieb SL, Wolfe JT, Fox FE, et al. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alpha: a 10-year experience at a single institution. J Am Acad Dermatol 1996; 35: 946-57.
30. Duvic M, Hester JP, Lemak NA. Photopheresis therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1996; 35: 573-9.
31. Aringer M, Graninger WB, Smolen JS, et al. Photopheresis treatment enhances CD95 (fas) expression in circulating lymphocytes of patients with systemic sclerosis and induces apoptosis. Br J Rheumatol 1997; 36: 1267.